Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in anti-BRAF therapies for lung cancer. | Invest New Drugs | 2021 | 33474634 | PubTator, text mining | PubMed |
| Development of Possible Next Line of Systemic Therapies for Gemcitabine-Resistant Biliary Tract Cancers: A Perspective from Clinical Trials. | Biomolecules | 2021 | 33451059 | PubTator, text mining | PubMed |
| Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer. | Int J Mol Sci | 2021 | 33435440 | PubTator, text mining | PubMed |
| Three cases of BRAF mutation negative Erdheim-Chester disease with a challenging distinction from IgG4-related disease. | Allergy Asthma Clin Immunol | 2021 | 33407743 | PubTator, text mining | PubMed |
| MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit. | NPJ Breast Cancer | 2021 | 33398005 | PubTator, text mining | PubMed |
| Targeting the Ras pathway in pediatric hematologic malignancies. | Curr Opin Pediatr | 2021 | 33394740 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
| The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan. | Int J Clin Oncol | 2021 | 33385275 | PubTator, text mining | PubMed |
| Isobaric tags for relative and absolute quantitation-based proteomics analysis of the effect of ginger oil on bisphenol A-induced breast cancer cell proliferation. | Oncol Lett | 2021 | 33376534 | PubTator, text mining | PubMed |
| Inhibition of RAF dimers: it takes two to tango. | Biochem Soc Trans | 2021 | 33367512 | PubTator, text mining | PubMed |
| LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors. | Clin Cancer Res | 2021 | 33355204 | PubTator, text mining | PubMed |
| Indeterminate Dendritic Cell Tumor With Persistent Complete Metabolic Response to BRAF/MEK Inhibition. | Hemasphere | 2021 | 33324955 | PubTator, text mining | PubMed |
| Molecular characteristics of uveal melanoma and intraocular tumors. | Oncol Lett | 2021 | 33240415 | PubTator, text mining | PubMed |
| Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma. | Mol Cancer Ther | 2021 | 33158997 | PubTator, text mining | PubMed |
| Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents. | Mol Cancer Res | 2021 | 33154093 | PubTator, text mining | PubMed |
| The MEK/ERK Network as a Therapeutic Target in Human Cancer. | Mol Cancer Res | 2021 | 33139506 | PubTator, text mining | PubMed |
| An Overview of Genetic Information of Latent Mycobacterium tuberculosis. | Tuberc Respir Dis (Seoul) | 2021 | 33121230 | PubTator, text mining | PubMed |
| Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non-small Cell Lung Cancer. | Clin Cancer Res | 2021 | 33046516 | PubTator, text mining | PubMed |
| The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder. | Int J Cancer | 2021 | 33006377 | PubTator, text mining | PubMed |
| Role of serine 365 in BRAF V600E sensitivity to RAF inhibition. | Pigment Cell Melanoma Res | 2021 | 33000894 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=41